Circular RNA PTPN4 Contributes to Blood-Brain Barrier Disruption during Early Epileptogenesis.
Jiurong Yang1, Yang Hu1, Feiyu Wang1
1Department of Pharmacology, Medical School of Southeast University, Nanjing, 210009, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|December 14, 2025
Summary
Circular RNA PTPN4 (CircPTPN4) is elevated in early epilepsy, disrupting the blood-brain barrier. Targeting this circular RNA may preserve barrier integrity and reduce seizures.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) regulate gene expression and are implicated in brain development and pathology.
- Epilepsy involves complex molecular changes affecting brain function and integrity.
Purpose of the Study:
- To investigate the role of CircPTPN4 in epileptogenesis and blood-brain barrier (BBB) integrity.
- To elucidate the molecular mechanism underlying CircPTPN4's function in epilepsy.
Main Methods:
- Murine temporal lobe epilepsy model.
- Analysis of CircPTPN4 expression in brain tissue and plasma.
- Investigation of CircPTPN4's effect on brain microvascular endothelial cells (BMECs) and BBB integrity.
- Molecular mechanism studies involving RNA sequencing, miRNA analysis, and pathway analysis (p38/MAPK).
Main Results:
- CircPTPN4 expression is elevated in early epileptogenesis.
- CircPTPN4 overexpression disrupts tight junctions in BMECs, impairing BBB integrity.
- CircPTPN4 acts as a molecular sponge for miR-145a-5p, upregulating ECE-1 and subsequently ET-1 production.
- Activation of the p38/MAPK pathway by ET-1 downregulates tight junction proteins.
- Knockdown of CircPTPN4 ameliorates BBB disruption and reduces seizure frequency.
Conclusions:
- The CircPTPN4/miR-145a-5p/ECE-1 axis is a key player in early epileptogenesis and BBB dysfunction.
- CircPTPN4 serves as a potential diagnostic biomarker for early-stage epilepsy.
- Targeting CircPTPN4 offers a therapeutic strategy for preserving BBB integrity and managing epilepsy.


